Sanj K. Patel
CHAIRMAN & CEO, Director · Kiniksa Pharmaceuticals International, plc
- 2024
- Sep 3, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Sanj K. Patel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John F. Paolini - $8.00M in KNSA purchases and sales in the last 12 months
- Mark Ragosa - $3.78M in KNSA purchases and sales in the last 12 months
- Michael R. Megna - $2.64M in KNSA purchases and sales in the last 12 months
- Barry D. Quart - $1.85M in KNSA purchases and sales in the last 12 months
- Eben Tessari - $523K in KNSA purchases and sales in the last 12 months
- G. Bradley Cole - $299K in KNSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sanj K. Patel?
Sanj K. Patel is a corporate insider, tracked as CHAIRMAN & CEO, Director of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sanj K. Patel submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Sanj K. Patel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 13 open-market sales ($41.49M) across all tracked filings.
